Related Experiment Video
Updated: Jul 19, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Endothelial dysfunction and restenosis following percutaneous coronary intervention
Panuratn Thanyasiri1, Krishna Kathir, David S Celermajer
1Department of Cardiology, Royal Prince Alfred Hospital, Missenden Rd, Camperdown 2050, Sydney, Australia.
International Journal of Cardiology
|November 10, 2006
Summary
Endothelial dysfunction, a reduction in coronary artery dilation, may independently contribute to restenosis after percutaneous coronary intervention (PCI). This study found impaired endothelium-dependent dilation in patients with restenosis, even in areas separate from the stented lesion.
Area of Science:
- Cardiovascular Research
- Interventional Cardiology
- Vascular Biology
Background:
- Restenosis following percutaneous coronary intervention (PCI) is a significant clinical challenge.
- While factors like vessel size and diabetes contribute, restenosis also occurs in low-risk patients, suggesting other independent risk factors.
- Endothelial dysfunction is hypothesized as a potential independent risk factor for restenosis.
Purpose of the Study:
- To investigate whether endothelial dysfunction is an independent risk factor for restenosis after PCI.
- To assess coronary artery diameter changes in response to acetylcholine and nitroglycerine in patients with and without restenosis.
Main Methods:
- Studied 20 patients post-PCI, matched for restenosis (10) and no restenosis (10).
- Administered acetylcholine (ACh) and nitroglycerine (GTN) via infusion catheter into the target artery.
- Measured arterial segment diameter changes proximal and distal to the PCI site.
Main Results:
- Significant impairment in endothelium-dependent dilation (acetylcholine) was observed in patients with restenosis compared to those without, both proximal and distal to the stented area (p<0.001).
- No significant difference in response to nitroglycerine (GTN) was found between groups.
- A significant negative correlation was found between endothelium-dependent dilation and percent restenosis (r=-0.65, p=0.003).
Conclusions:
- Coronary endothelium-dependent dilation is reduced in patients with restenosis, even in arterial segments not directly involved by the stented lesion.
- These findings support the hypothesis that endothelial dysfunction plays a role in the development of restenosis after PCI.
- Endothelial dysfunction may be an independent contributor to restenosis, warranting further investigation.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...